Search published articles


Showing 4 results for Mohammed

Mohammed Omer Abaker Gibreel , Mubarak El Saeed Elkarsani , Munsour Mohammed Munsour , Hanan Babeker El Taher ,
Volume 12, Issue 6 (Nov - Dec 2018)
Abstract

ABSTRACT
            Background and objectives: This study aimed to characterize the spectrum of β-thalassemia mutations and haplotypes of sickle cell anemia in Beja tribes and other minor groups living in Port Sudan, Sudan.
            Methods: This descriptive cross-sectional study was carried out from March 2011 to July 2013. Overall, 209 anemic patients were screened for hemoglobinopathy by capillary electrophoresis. The subjects were genotyped for β-thalassemia mutation by amplified refractory mutation system and for sickle cell haplotype by restriction-fragment length polymorphism. 
            Results: Of the 209 patients, 29 (13.87%) showed the typical -88(C→T) β-thalassemia mutation and 27 (12.91%) had sickle cell anemia, of whom 15 (55.6%) were heterozygous AS and 12 (44.4%) were homozygous SS. Based on results of the restriction-fragment length polymorphism; all subjects were with Benin haplotype (Benin/Benin).
            Conclusion: Based on the results of this study, it is recommended to perform a potential carrier screening for the -88 (C→T) mutation and sickle cell Benin haplotype by DNA analysis.
            KEYWORDS: Genotyping, Hemoglobinopathies, Thalassemia, Sickle cell disease, Port Sudan.

Ebrahim Mohammed Abed Ahamid Ahmed, Babker Ahmed Mohamed , Bakri Yousf Mohamed Nour, Babiker Saad Almugadam ,
Volume 18, Issue 4 (Jul-Aug 2024)
Abstract

Background: Acute ischemic stroke occurs when blood clots obstruct blood vessels within the brain. Platelets (Plts) are integral to the pathophysiology of stroke. This research aimed to explore the relationship between Plt quality and Plt indices in the context of acute ischemic stroke.
Methods: This cross-sectional investigation involved 100 patients diagnosed with acute ischemic stroke at Kosti Teaching Hospital and Alyammama Hospitals. The diagnosis was confirmed using brain CT imaging and electrocardiography (ECG). Blood samples were collected in EDTA-containing tubes within 24 hours following the commencement of treatment and were subsequently analyzed for Plt count, mean Plt volume (MPV), Plt distribution width (PDW), and plateletcrit (PCT) utilizing a hematological analyzer. Data were analyzed using GraphPad Prism software.
Results: Platelet counts negatively correlated with PDW [r=-0.074, P=0.459; R=-0.023, P=0.815], MPV [r=-0.130, P=0.194; R=-0.081, P=0.417], and diastolic blood pressure [r= -0.023, P=0.818; R= -0.024, P=0.805]; and positively correlated with PCT [r= 0.103, P=0.308; R=0.143, P=0.155] and diastolic blood pressure [r=0.022, P=0.823; R= 0.008, P=0.932]. Moreover, PDW positively correlated with systolic blood pressure [r=0.105, P=0.298; R= 0.147, P=0.148] and diastolic blood pressure [r=0.146, P=0.145; R=0.173, P=0.084]. Based on Spearman but not Pearson correlation, PDW showed a negative correlation with PCT [r=-0.005, P=0.959; R=0.010, P=0.929].
Conclusion: The study shows a correlation between Plt count and indices in ischemic stroke patients. The research also presented evidence concerning the relationship between diastolic and systolic blood pressure and Plt counts and indices.

 

Mohammed Fabin, Jayakrishnan Jayakumar, Swathy Shanker,
Volume 18, Issue 4 (Jul-Aug 2024)
Abstract

Background: Diabetes Mellitus (DM) is a metabolic disorder whose pathophysiology has been linked to various genetic and environmental factors. The main mechanism of the development of complications has been implicated as inflammation-mediated. Various blood cell parameters are being used as early indicators of inflammation-mediated endothelial dysfunction; thereby predicting the severity or prognosis of DM. In this study, we aimed to evaluate the role of platelet-to-lymphocyte ratio (PLR) in predicting glycemic control in patients with DM.
Methods: This is a retrospective, hospital-based study conducted from August 2023 to December 2023. A total of 134 patients were included in the study. The hematological and biochemical reports of the study population were retrieved, and the data obtained was analyzed using SPSS software version 16.0.
Results: In this study, it has been found that PLR is significantly increased in patients suffering from DM with poor glycemic control compared to those patients with good glycemic control (P<0.001). In concordance with other studies, a positive association was observed between PLR and disease severity.
Conclusion: Based on the findings of the study, PLR may be used as a predictive marker in assessing the severity and prognosis of DM; however, the exact cut-off value is yet to be determined.

 

Esmail Samadian, Arash Golalipour, Mohammadali Vakili, Hasan Mohammed, Azam Rashidbaghan,
Volume 20, Issue 1 (1-2026)
Abstract

Background: The high global mortality of breast cancer in women necessitates novel therapies with fewer side effects.. Urtica dioica agglutinin (UDA), a lectin from stinging nettle, exhibits antiproliferative properties in various cancers, but its effect on breast cancer cells remain underexplored. This study evaluates UDA’s cytotoxic potential against Michigan Cancer Foundation-7 (MCF-7) breast cancer cells while assessing its impact on  non-tumorigenic human mammary epithelial (MCF-10A) and Human embryonic kidney (HEK-293) cells.
Methods: UDA purification was performed via affinity chromatography from Urtica dioica rhizomes, confirmed by SDS-PAGE (8.5–9.5 kDa) and agglutination assays. MCF-7, MCF-10A, and HEK-293 cells were treated with different concentrations of UDA (7.5–480 µg/ml) for 24 and 48 hours. Cytotoxicity was assessed using MTT assays to measure cell viability.
Results: UDA significantly inhibited MCF-7 proliferation in a dose- and time-dependent manner (P < 0.01 at 24 hours; P < 0.0001 at 48 hours). At 240 µg/ml (during 48 hours), viability dropped below 50%, while normal HEK-293 cells showed <30% toxicity. MCF-10A proliferation remained unaffected, even at 480 µg/ml. IC50 was 389.7 207.0 μg/mL for 24 and 48 hours. 
Conclusion: UDA targets breast cancer cells (MCF-7) with minimal toxicity to normal cells, positioning it as a promising anticancer candidate. Determining the mechanism of its action and apoptosis-inducing potential needs further research in the future.  .

Page 1 from 1